Nicotine pellet composition, nicotine pellet pouch and method of making same

By employing multi-layer coating technology in the nicotine microsphere composition, the problems of fluidity and unstable release of nicotine products were solved, achieving rapid or uniform release of nicotine and stable release of aroma, thereby improving the stability and fluidity of the product.

CN120346185BActive Publication Date: 2026-03-31HOUPU (ZHUHAI) TECHNOLOGY CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410081347.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-19
Publication Date
2026-03-31
Estimated Expiration
2044-01-19

AI Technical Summary

Technical Problem

Existing nicotine products suffer from poor flowability, unstable nicotine release, and unstable aroma release, which affect product stability and shelf life.

Method used

The nicotine microcapsule composition includes blank capsule cores, binders, sweeteners, pH adjusters, cellulose and cellulose derivatives, polymer coating materials, lubricants, flavorings and solvents. By forming a single or multiple layers of drug loading or coating on the blank capsule cores, the rapid or uniform release of nicotine is achieved. The polymer coating materials form a protective layer to prevent moisture, light, and air.

Benefits of technology

It achieves rapid or uniform and stable release of nicotine, improves the product's fluidity and stability, avoids the interaction of compound ingredients during the preparation process, and ensures stable release of aroma.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120346185B_ABST
    Figure CN120346185B_ABST
Patent Text Reader

Abstract

The present application relates to a nicotine pellet composition, a nicotine pellet pouch and a preparation method thereof. The nicotine pellet composition comprises nicotine, a blank pellet core, a binder, a sweetener, a pH regulator, cellulose and cellulose derivatives, a high-molecular coating material, a lubricant, a flavoring agent and a solvent. The blank pellet core is loaded with the nicotine, and the high-molecular coating material forms a single layer or multiple layers of drug loading or coating on the blank pellet core. When the high-molecular coating material forms multiple layers of drug loading or coating, it comprises, from inside to outside, a separation layer, a drug-containing layer, a protective layer and a drug-loading layer. The present application provides a nicotine pellet composition and a nicotine pellet pouch with good fluidity, stable nicotine release and stable aroma release, which can be used for the treatment of smoking cessation or nicotine dependence.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of nicotine composition technology, and particularly to a nicotine microcapsule composition, a nicotine microcapsule lozenge, and a method for preparing the same. Background Technology

[0002] Tobacco-free, pouch-packaged oral nicotine products are increasingly popular with consumers due to their proven harm reduction effects, ease of use, and novel flavors. These products allow users to enjoy nicotine without contact with tobacco. Nicotine pouches are typically placed between the upper and lower gums and lips for a certain period, allowing nicotine to be absorbed directly through the mucous membranes. They eliminate the harmful effects of nitrosamines, smoke, and various carcinogens found in traditional tobacco products, and are often used for smoking cessation or the treatment of nicotine dependence.

[0003] Existing nicotine pouches typically consist of nicotine mixed with excipients to form granules, which are then packaged in small non-woven fabric bags. However, nicotine granules tend to aggregate and adhere to the surface of containers or packaging materials, especially as the size of the nicotine granules decreases, increasing both the tendency and strength of aggregation. Furthermore, the inconsistent shape and size of the granules lead to unstable nicotine release rates. In addition, the flowability of these nicotine granules is affected by fragrances and moisture, resulting in decreased flowability. Moreover, nicotine hydrolysis releases nicotine alkaloids, which can mask the aroma of the fragrances, causing off-odors. Additionally, product stability is compromised, and shelf life is shortened.

[0004] Chinese Patent CN107259634A (publication date: October 20, 2017) discloses an oral product comprising a body that can be fully contained in the oral cavity. The body comprises: an extruded oral-stabilizing polymer matrix, the oral product containing at least 10% by weight of one or more oral-stabilizing polymers selected from polyurethane, polyacrylate, polyethylene, SEBS, SBS, or combinations thereof; at least 10% by weight of cellulose fibers embedded in the oral-stabilizing polymer matrix, forming a cellulose-polymer matrix; and nicotine or a derivative thereof dispersed and adsorbed in the cellulose-polymer matrix, such that the nicotine or its derivative is released from the body when the body is contained within the oral cavity and comes into contact with saliva. The body has a compressibility factor between 45% and 90% at 250 N and an elastic percentage between 75% and 90%. This patent uses an extrusion spheroidization process to prepare nicotine compositions, including spherical nicotine compositions. This patent does not disclose nicotine microsphere compositions made using blank pellet cores and nicotine and excipients.

[0005] Chinese patent CN114521669A (publication date: 2022.05.24) discloses a nicotine-stabilized oral cigarette product, comprising a binder, a nicotine source, a pH adjuster, core material particles, and a filler. Its preparation method includes the following steps: (1) Preparation of a nicotine-stabilized mixed solution: dissolving a polymer material in anhydrous ethanol, stirring until homogeneous, and then adding a nicotine source and a pH adjuster; (2) Mixing the filler with the solution in (1): mixing a sweetener, flavoring agent, and humectant with the solution obtained in (1) until homogeneous; (3) adding the solution obtained in (2) to the core material particles, stirring until absorbed, and then drying overnight to obtain flavored nicotine-stabilized oral cigarette particles. It is obvious that this patented preparation method cannot guarantee that the nicotine content on each core material particle is uniform.

[0006] The existing technology has failed to provide a nicotine product that has good fluidity, stable nicotine release, and stable aroma release.

[0007] Therefore, existing technologies need to be improved. Summary of the Invention

[0008] The prior art has failed to provide a nicotine product with good flowability, stable nicotine release, and stable aroma release. Therefore, the present invention provides a nicotine microcapsule composition, a nicotine microcapsule lozenge, and a method for preparing the same to solve the above problems.

[0009] To achieve the above objectives, in a first aspect, the present invention provides a nicotine microcapsule composition comprising nicotine, a blank capsule core, a binder, a sweetener, a pH adjuster, cellulose and cellulose derivatives, a polymeric coating material, a lubricant, a flavoring, and a solvent, wherein the blank capsule core is loaded with the nicotine, and the polymeric coating material forms a single layer or multiple layers of drug loading or coating on the blank capsule core.

[0010] In one implementation, when the polymer coating material forms a multilayered drug-loaded or coated layer, it includes, from the inside out, an isolation layer, a drug-containing layer, a protective layer, and a drug-loaded layer.

[0011] In one implementation, the nicotine comprises any one or more of the following: free base nicotine, nicotine salts, nicotine in a matrix or organometallic complex, nicotine-ion exchange resin combination, nicotine inclusion complex or any non-covalently bound nicotine, nicotine lactate, nicotine malate, nicotine salicylate, nicotine resin complex, nicotine cyclodextrin encapsulated complex, nicotine hydrochloride, nicotine dihydrochloride, nicotine tartrate, nicotine tartrate dihydrate, nicotine sulfate, nicotine zinc chloride, and nicotine benzoate.

[0012] In one implementation, the blank pellet core includes a hydrophilic glycosyl pellet core and / or a hydrophobic cellulose pellet core, wherein the hydrophilic glycosyl pellet core is composed of a water-soluble glycosyl material, and the hydrophobic cellulose pellet core is composed of a water-insoluble cellulose material.

[0013] In one implementation, the adhesive comprises any one or more of povidone, cellulose derivatives, pregelatinized starch, sugar alcohols, gelatin, gum arabic, sodium alginate, and polyethylene glycol.

[0014] In one implementation, the sweetener includes any one or more of acesulfame potassium, cyclamate, saccharin, sodium saccharin, sucralose, neotame, sodium cyclohexylsulfamate, aspartame, stevia, licorice, disodium glycyrrhizate, tripotassium and trisodium glycyrrhizate, glucose, fructose, sucrose, maltose, starch sugar and lactose, sorbitol, maltitol, isomaltitol, xylitol, lactitol, mannitol and erythritol.

[0015] In one implementation, the pH adjuster comprises any one or more of acetates, carbonates of alkali metals or ammonium, lactates, glycinates, gluconates, borates, glycerol phosphates or citrates, phosphates, metal hydroxides, and mixtures thereof.

[0016] In one implementation, the cellulose and cellulose derivatives include any one or more of wheat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, bran fiber, bamboo fiber, pandan fiber, powdered cellulose, and polymer materials.

[0017] In one implementation, the polymer coating material includes a sugar material or a polymer material. The sugar material includes any one or more of syrup, colored syrup, paste, talc, and beeswax. The polymer material includes any one or more of hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, methylcellulose, methacrylic acid copolymer, methacrylate copolymer, cellulose acetate phthalate, polyvinylpyrrolidone, polyvinylpyrrolidone, and polyethylene glycol.

[0018] In one implementation, the lubricant includes a hydrophobic lubricant and a hydrophilic lubricant, wherein the hydrophobic lubricant includes any one or more of stearic acid, magnesium stearate, calcium stearate, glyceryl behenate, micronized silica gel, talc, vegetable oil, polyethylene glycol, and sodium dodecyl sulfate, and the hydrophilic lubricant includes sodium stearate fumarate.

[0019] In one implementation, the flavorings include any one or more of the following: bergamot flavoring, eucalyptus flavoring, citrus flavoring, lemon flavoring, peppermint flavoring, peppermint flavoring, menthol, licorice flavoring, wintergreen flavoring, tobacco flavoring, coffee flavoring, vanilla flavoring, lime flavoring, apple flavoring, peach flavoring, mango flavoring, cherry flavoring, blueberry flavoring, strawberry flavoring, cola flavoring, cinnamon flavoring, and watermelon flavoring.

[0020] In one implementation, the solvent includes water and / or an organic solvent, which includes any one or more of aromatic hydrocarbons, aliphatic hydrocarbons, alicyclic hydrocarbons, halogenated hydrocarbons, alcohols, ethers, esters, ketones, glycol derivatives, and other types such as acetonitrile, pyridine, and phenol.

[0021] In a second aspect, the present invention also provides a nicotine microsphere oral bag, which includes a nonwoven fabric pouch and the nicotine microsphere composition described in any one of the above-mentioned claims contained within the nonwoven fabric pouch.

[0022] Thirdly, the present invention also provides a method for preparing a nicotine microcapsule lozenge, which is used to prepare the above-mentioned nicotine microcapsule lozenge, and specifically includes the following steps:

[0023] S1. Weighing and preparation process: Weighing materials; preparing polymer coating materials according to the prescription;

[0024] S2, Drug-loaded coating process: After the polymer coating material is prepared, it is placed into the spray gun hopper. The weighed solid materials are sequentially fed into the solid hopper of the fluidized bed or centrifugal coating machine according to the prescription. The machine is turned on to carry out the fluidized bed coating or centrifugal coating process, so that the material is evenly wrapped on the pellet core and forms one or more layers of material to obtain nicotine-loaded microcapsules.

[0025] S3. Drying process: Place the granulated nicotine microspheres into a drying oven or fluidized bed for drying;

[0026] S4. Filling process: Transfer the dried nicotine microcapsules to the powder hopper of the granulation packaging machine, and put the non-woven fabric roll into the film hopper of the granulation packaging machine. Start the granulation packaging machine to carry out the filling process, so that the formed nicotine microcapsules are filled into non-woven fabric bags to obtain the nicotine microcapsule oral bags.

[0027] Beneficial Effects: The nicotine microsphere composition and nicotine microsphere lozenges provided by this invention achieve rapid and uniform stable nicotine release by forming single or multiple layers of drug-loaded or coated material on blank microsphere cores, resulting in relatively stable nicotine content and release, as well as stable aroma release. The formation of the drug-loaded or coated layer provides moisture-proof, light-proof, and air-isolated effects, increasing the stability of the nicotine microsphere composition. The preparation method provided by this invention eliminates the need for flow aids during filling, resulting in smaller weight differences compared to powder or granule filling, and avoids interactions between compound components during preparation, leading to better flowability of the resulting nicotine microsphere composition and nicotine microsphere lozenges. This invention provides a nicotine product with good flowability, stable nicotine release, and stable aroma release, which can be used for smoking cessation or treatment of nicotine dependence. Attached Figure Description

[0028] Figure 1 This is a flowchart of the steps involved in preparing the nicotine microcapsule oral bag provided by the present invention.

[0029] The realization of the objective, functional features and advantages of the present invention will be further explained in conjunction with the embodiments and with reference to the accompanying drawings. Detailed Implementation

[0030] To make the objectives, technical solutions, and advantages of this invention clearer, the invention will be further described in detail below with reference to the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention. Furthermore, the terms "one embodiment," "some embodiments," "example," "specific example," or "some examples," etc., described below refer to specific features, structures, materials, or characteristics described in connection with that embodiment or example, which are included in at least one embodiment or example of the invention. In this specification, the illustrative expressions of the above terms do not necessarily refer to the same embodiment or example. Moreover, the technical features involved in the various embodiments of the invention can be combined with each other as long as they do not conflict with each other.

[0031] This invention provides a nicotine microcapsule composition comprising nicotine, a blank capsule core, a binder, a sweetener, a pH adjuster, cellulose and cellulose derivatives, a polymeric coating material, a lubricant, a flavoring, and a solvent. The blank capsule core is loaded with the nicotine, and the polymeric coating material forms a single layer or multiple layers of drug loading or coating on the blank capsule core. When the polymeric coating material forms multiple layers of drug loading or coating, it sequentially includes, from the inside out, an isolation layer, a drug-containing layer, a protective layer, and a drug-loading layer. Specifically, when the blank capsule core is coated with a single layer of non-functional coating material, the nicotine is released rapidly during use; when the blank capsule core is coated with multiple layers of functional coating material, the nicotine is released uniformly and slowly during use.

[0032] The nicotine mentioned herein includes any one or more of the following: free nicotine base, nicotine salts, nicotine in a matrix or organometallic complex, nicotine-ion exchange resin combinations, nicotine inclusion complexes or any non-covalently bound nicotine, nicotine lactate, nicotine malate, nicotine salicylate, nicotine resin complexes, nicotine cyclodextrin-encapsulated complexes, nicotine hydrochloride, nicotine dihydrochloride, nicotine tartrate, nicotine tartrate dihydrate, nicotine sulfate, nicotine zinc chloride, and nicotine benzoate. The nicotine mentioned herein also refers to synthetic nicotine and nicotine extracted from natural tobacco.

[0033] The blank pellet core refers to the masterbatch necessary for preparing the skeleton-type microspheres. The blank pellet core includes hydrophilic glycosyl pellet cores and / or hydrophobic cellulose pellet cores, which are spherical or near-spherical solids with a diameter of less than 2.5 mm. The hydrophilic glycosyl pellet core is composed of water-soluble sugary materials, and the hydrophobic cellulose pellet core is composed of water-insoluble cellulose materials. Further, the hydrophilic glycosyl pellet core includes sucrose blank pellet cores or starch blank pellet cores, and the hydrophobic cellulose pellet core includes microcrystalline cellulose blank pellet cores.

[0034] The adhesive referred to herein is a pharmaceutically acceptable adhesive. The adhesive includes any one or more of povidone, cellulose derivatives, pregelatinized starch, sugar alcohols, gelatin, gum arabic, sodium alginate, and polyethylene glycol.

[0035] The sweeteners mentioned herein refer to artificially synthesized and / or naturally extracted sweet substances. The sweeteners include any one or more of the following: acesulfame potassium, cyclamate, saccharin, sodium saccharin, sucralose, neotame, sodium cyclohexylsulfamate, aspartame, stevia, licorice, disodium glycyrrhizate, tripotassium and trisodium glycyrrhizate, glucose, fructose, sucrose, maltose, starch sugar and lactose, sorbitol, maltitol, isomaltitol (paragentitol), xylitol, lactitol, mannitol, and erythritol.

[0036] The pH adjuster includes any one or more of acetate, alkali metal or ammonium carbonate, lactate, glycinate, gluconate, borate, glycerol phosphate or citrate, phosphate, metal hydroxide and mixtures thereof.

[0037] The cellulose and cellulose derivatives mentioned herein refer to substances that are pharmaceutically acceptable for use as diluents, lubricants, sustained-release agents, binders, disintegrants, glidants, stabilizers, or excipients, and are insoluble in water. Further, the cellulose and cellulose derivatives include any one or more of wheat fiber, pea fiber, rice fiber, corn fiber, oat fiber, tomato fiber, barley fiber, rye fiber, beet fiber, buckwheat fiber, potato fiber, cellulose fiber, apple fiber, cocoa fiber, bran fiber, bamboo fiber, vanilla fiber, powdered cellulose, and polymer materials. The cellulose and cellulose derivatives and / or polymer materials are permeable to saliva and are partially or completely dissolved in the nicotine microcapsule composition.

[0038] The polymer coating material includes sugar materials or polymer materials. The sugar materials include any one or more of syrups, colored syrups, gels, talc, and beeswax. The polymer materials include any one or more of hydroxypropyl methylcellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, methylcellulose, methacrylic acid copolymers, methacrylate copolymers, cellulose acetate phthalate, polyvinylpyrrolidone, polyvinylpyrrolidone, and polyethylene glycol. The polymer coating material, by coating a solid surface, forms one or more multifunctional protective layers of varying thicknesses and elasticities that adhere tightly to the surface, and is saliva-soluble.

[0039] The lubricant includes both hydrophobic and hydrophilic lubricants. The hydrophobic lubricant includes any one or more of stearic acid, magnesium stearate, calcium stearate, glyceryl behenate, micronized silica gel, talc, vegetable oil, polyethylene glycol, and sodium dodecyl sulfate. The hydrophilic lubricant includes sodium stearate fumarate. The lubricant is used to effectively reduce the friction between particles or powders to enhance their flowability, lubricity, or anti-sticking properties.

[0040] The flavorings and fragrances mentioned herein refer to substances with a specific aroma and flavor, composed of hydrocarbons, alcohols, acids, esters, lactones, ethers, aldehydes, ketones, acetals, ketals, phenols, macrocyclic compounds, polycyclic compounds, heterocyclic compounds containing nitrogen, oxygen, and sulfur elements, as well as halogenated compounds or nitrile compounds. Further, the flavorings and fragrances include any one or more of the following: bergamot flavoring, eucalyptus flavoring, citrus flavoring, lemon flavoring, peppermint flavoring, peppermint flavoring, menthol, licorice flavoring, wintergreen flavoring, tobacco flavoring, coffee flavoring, vanilla flavoring, lime flavoring, apple flavoring, peach flavoring, mango flavoring, cherry flavoring, blueberry flavoring, strawberry flavoring, cola flavoring, cinnamon flavoring, and watermelon flavoring.

[0041] The solvent includes water and / or an organic solvent, wherein the organic solvent includes any one or more of aromatic hydrocarbons, aliphatic hydrocarbons, alicyclic hydrocarbons, halogenated hydrocarbons, alcohols, ethers, esters, ketones, glycol derivatives, and other types such as acetonitrile, pyridine, and phenol.

[0042] For details, please refer to [link / reference]. Figure 1 , Figure 1 This is a flowchart illustrating the steps of preparing the nicotine microsphere lozenge provided by the present invention. The present invention also provides a nicotine microsphere lozenge, comprising a nonwoven fabric pouch and the nicotine microsphere composition described in any one of the above embodiments contained within the nonwoven fabric pouch.

[0043] This invention also provides a method for preparing a nicotine microcapsule lozenge, which is used to prepare the above-mentioned nicotine microcapsule lozenge, and specifically includes the following steps:

[0044] S1. Weighing and preparation process: Weighing materials; preparing polymer coating materials according to the prescription;

[0045] S2, Drug-loaded coating process: After the polymer coating material is prepared, it is placed into the spray gun hopper. The weighed solid materials are sequentially fed into the solid hopper of the fluidized bed or centrifugal coating machine according to the prescription. The machine is turned on to carry out the fluidized bed coating or centrifugal coating process, so that the material is evenly wrapped on the pellet core and forms one or more layers of material to obtain nicotine-loaded microcapsules.

[0046] S3. Drying process: Place the granulated nicotine microspheres into a drying oven or fluidized bed for drying;

[0047] S4. Filling process: Transfer the dried nicotine microcapsules to the powder hopper of the granulation packaging machine, and put the non-woven fabric roll into the film hopper of the granulation packaging machine. Start the granulation packaging machine to carry out the filling process, so that the formed nicotine microcapsules are filled into non-woven fabric bags to obtain the nicotine microcapsule oral bags.

[0048] The present invention provides the following embodiments to illustrate the technical solution of the present invention.

[0049] Example 1: Preparation of nicotine microcapsule oral pouches for rapid nicotine release and preparation process, as well as in vitro dissolution data.

[0050] Weigh the required materials according to the formula in Table 1.

[0051] Table 1. Formulation of the nicotine microsphere composition in Example 1:

[0052]

[0053] The materials in Table 1 are prepared according to the following methods:

[0054] Step 1: Prepare the medicated coating solution: Heat 100g of 95% ethanol to 50℃, then add nicotine ditartaric acid dihydrate and disperse using an emulsifier for 5 minutes until clear. Then cool to 30℃ and add povidone, dispersing using an emulsifier for 5 minutes until completely dissolved. Next, add neotame sequentially, dispersing using an emulsifier for 5 minutes until completely dissolved. Then add the cooling agent, dispersing using an emulsifier for 5 minutes until completely dissolved. Finally, add the flavoring, dispersing using an emulsifier for 10-15 minutes until completely dissolved.

[0055] Step 2, Drug Coating Process: Put the blank sucrose pellet core into the material bin of the centrifugal granulation and coating machine, put the drug-containing coating liquid prepared in Step 1 into the spray gun bin, set the machine parameters according to Table 2, start the machine to carry out the centrifugal coating process for 60 minutes, and evenly coat the sucrose pellet core with the drug-containing coating liquid to form a drug-containing material layer.

[0056] Table 2. Preparation process parameters in Example 1:

[0057]

[0058] Step 3, Drying process: Place the microspheres obtained in step 2 into a drying oven and dry them at a temperature of 45℃ for 4-6 hours.

[0059] Step 4, Filling process: Transfer the dried nicotine microspheres obtained in step 3 to the powder hopper of the granule packaging machine, and put the non-woven fabric roll into the film hopper of the granule packaging machine; start the granule packaging machine to carry out the filling process.

[0060] The nicotine microcapsule composition oral bag prepared in Example 1 was subjected to in vitro dissolution testing, and the experimental data are shown in Table 3.

[0061] Table 3. Dissolution data outside the oral bag of nicotine microcapsules for rapid nicotine release in Example 1:

[0062]

[0063] As can be seen from Example 1, the nicotine microsphere oral pouches prepared by using centrifugal granulation and coating process and microsphere coating method have the effect of rapidly releasing nicotine.

[0064] Example 2: Preparation of nicotine microcapsule oral pouches for slow-release nicotine and the preparation process, as well as in vitro dissolution data.

[0065] Weigh the required materials according to the formula in Table 4.

[0066] Table 4. Formulation of Nicotine Microparticle Composition in Example 2

[0067]

[0068] The materials in the formulations in Table 4 are prepared using the following methods:

[0069] A. Isolation layer coating process

[0070] Step A1: Prepare the separating layer coating solution: Dissolve the prescribed amounts of ethyl cellulose and magnesium stearate in 95% ethanol. Weigh the blank sucrose pellet cores according to the prescribed amounts.

[0071] Step A2, Isolation Layer Coating Process: After preparing the ethyl cellulose and magnesium stearate alcohol solution, put it into the spray gun hopper. Put the weighed blank sucrose pellet core into the fluidized bed solid hopper. Set the machine parameters according to Table 5, start the machine to carry out the fluidized bed coating process, and at the same time carry out fluidized bed drying for 60 minutes. The ethyl cellulose and magnesium stearate materials are evenly coated on the sucrose pellet core to form an isolation layer.

[0072] Table 5. Coating process parameters for the release layer

[0073]

[0074] Step A3: Drying process: The micro-pellet drying process is completed simultaneously with the isolation layer coating.

[0075] B. Drug-coating process

[0076] Step B1: Prepare the drug-coating solution: Dissolve the prescribed amounts of nicotine ditartaric acid dihydrate, povidone, acesulfame potassium, magnesium stearate, flavoring agent, and sodium carbonate aqueous solution in 95% ethanol to obtain solution A. Weigh the sugar pills coated with the isolation layer according to the prescribed amounts.

[0077] Step B2, Drug Coating Process: After preparing solution A, put it into the spray gun hopper. Put the weighed sugar pills coated with the isolation layer into the fluidized bed solid hopper. Set the machine parameters according to Table 6, start the machine to carry out the fluidized bed coating process, and at the same time carry out fluidized bed drying for 45 minutes to evenly coat the sugar pills with the isolation layer.

[0078] Table 6. Process parameters for drug-containing coating

[0079]

[0080] Step B3: Drying process: The micro-pellet drying process is completed simultaneously with the drug coating.

[0081] C. Protective coating process

[0082] Step C1: Prepare the protective coating solution: Dissolve the prescribed amounts of povidone and magnesium stearate in 95% ethanol. Weigh the nicotine microcapsules containing the drug coating according to the prescribed amounts.

[0083] Step C2, Protective Coating Process: Place the prepared polyvinyl alcohol and magnesium stearate solution into the spray gun hopper, and put the weighed nicotine microcapsules with drug coating into the fluidized bed solid hopper. Set the machine parameters according to Table 7, start the machine to carry out the fluidized bed coating process, and at the same time carry out fluidized bed drying for 30 minutes to evenly coat the nicotine microcapsules with drug coating.

[0084] Table 7. Protective Coating Process Parameters

[0085]

[0086] Step C3: Drying process: The drying process is completed simultaneously with the protective coating.

[0087] D. Drug coating process

[0088] Step D1: Prepare the drug-loaded coating solution: Dissolve the prescribed amounts of nicotine ditartaric acid dihydrate, methacrylate-ethyl acrylate copolymer, neotame, flavoring, and sodium carbonate aqueous solution in 95% ethanol to obtain solution B. Weigh the nicotine microspheres coated with the protective layer according to the prescribed amounts.

[0089] Step D2, Drug-loaded coating process: After preparing solution B, put it into the spray gun hopper. Put the weighed nicotine microcapsules coated with the protective layer into the fluidized bed solid hopper. Set the machine parameters according to Table 8, start the machine to carry out the fluidized bed coating process, and at the same time carry out fluidized bed drying for 60 minutes. The nicotine-containing composition is evenly coated on the sugar capsules after the isolation layer is applied.

[0090] Table 8. Drug Coating Process Parameters

[0091]

[0092] Step D3, Drying process: The drying process of micro-pellets is completed simultaneously with the drug-loaded coating.

[0093] Step D4, Filling Process: Transfer the dried nicotine microspheres to the powder hopper of the granule packaging machine, and place the non-woven fabric roll into the film hopper of the granule packaging machine. Start the granule packaging machine to carry out the filling process.

[0094] The nicotine microcapsule oral bags prepared in Example 2 were subjected to in vitro dissolution testing, and the experimental data are shown in Table 9.

[0095] Table 9. Extra-oral dissolution data of nicotine microcapsules for slow-release nicotine in Example 2.

[0096]

[0097] As can be seen from Example 2, the nicotine microsphere oral bag prepared by using the fluidized bed bottom spray coating and drying process and the microsphere coating method has the effect of slowly releasing nicotine.

[0098] In summary, the nicotine microsphere composition and nicotine microsphere lozenges provided by this invention, through the aforementioned preparation process, uniformly coat the nicotine composition onto the core of the microsphere. By forming a single or multiple layers of drug-loaded material or coating on the blank core, the effects of rapid and uniform stable release of nicotine are achieved, resulting in relatively stable nicotine content and release, as well as stable aroma release. Furthermore, after preparing nicotine and aroma into microspheres, the mass and contents of each microsphere are almost equal, and the drug release state is the same, achieving synchronous nicotine and aroma release, which can be maintained until complete nicotine release. The drug-loaded or coated material provides moisture-proof, light-proof, and air-isolated effects, increasing the stability of the nicotine microsphere lozenges. The preparation method provided by this invention eliminates the need for a flow aid during filling, resulting in smaller weight differences compared to powder or granule filling, and avoids interactions between compound components during preparation, leading to better flowability of the resulting nicotine microsphere composition and nicotine microsphere lozenges. This invention provides a nicotine product with good fluidity, stable nicotine release, and stable aroma release, which can be used for smoking cessation or treatment of nicotine dependence.

[0099] The above description is merely a preferred embodiment of the present invention and does not limit the patent scope of the present invention. Any equivalent structural or procedural transformations made based on the content of the present invention's specification and drawings, or direct or indirect applications in other related technical fields, are similarly included within the patent protection scope of the present invention.

Claims

1. A nicotine pellet composition characterized in that, It comprises nicotine bitartrate dihydrate, sucrose blank pellet core, povidone, acesulfame potassium, neotame, sodium carbonate, ethyl cellulose, methacrylic acid-ethyl acrylate copolymer, magnesium stearate, flavor and ethanol, the nicotine bitartrate dihydrate is loaded on the sucrose blank pellet core, a multi-layer drug-loaded or coating is formed on the sucrose blank pellet core, which comprises an isolation layer, a drug-containing layer, a protective layer and a drug-loaded layer from inside to outside; The preparation method of the multi-layer drug-loaded or coating formed on the sucrose blank pellet core is as follows: A. Isolation layer coating process: Step A1, preparation of isolation layer coating solution: dissolve the formula amount of ethyl cellulose and magnesium stearate in 95% ethanol and weigh the formula amount of sucrose blank pellet core, wherein the mass percentage of sucrose blank pellet core: ethyl cellulose: magnesium stearate is 90.0:7.1:2.9; Step A2, isolation layer coating process: after the prepared ethyl cellulose and magnesium stearate alcohol solution is placed into the spray gun material bin, the weighed blank sucrose pellet core is put into the fluidized bed solid material bin, the machine parameters are set according to the preset parameters, the machine is started to carry out the fluidized bed coating process, and the fluidized bed drying is carried out at the same time, the time is 60 minutes, the ethyl cellulose and magnesium stearate material is uniformly wrapped on the sucrose pellet core and forms an isolation layer; Step A3: drying process: the isolation layer coating is completed at the same time, and the sugar pellet after isolation layer coating is obtained; B. Drug-containing layer coating process: Step B1, preparation of drug-containing layer coating solution: dissolve the formula amount of nicotine bitartrate dihydrate, povidone, acesulfame potassium, magnesium stearate, flavor and sodium carbonate solution in 95% ethanol to obtain solution A, and weigh the formula amount of the sugar pellet after isolation layer coating prepared in step A, wherein the mass percentage of the sugar pellet after isolation layer coating: nicotine bitartrate dihydrate: povidone: acesulfame potassium: magnesium stearate: flavor: sodium carbonate solution is 80.0:6.0:8.8:2.0:1.0:1.2:1.0; Step B2, drug-containing layer coating process: after the prepared solution A is placed into the spray gun material bin, the weighed sugar pellet after isolation layer coating is put into the fluidized bed solid material bin, the machine parameters are set according to the preset parameters, the machine is started to carry out the fluidized bed coating process, and the fluidized bed drying is carried out at the same time, the time is 45 minutes, the nicotine-containing composition is uniformly wrapped on the sugar pellet after isolation layer coating; Step B3: drying process: the drug-containing layer coating is completed at the same time, and the nicotine micro-pellet after drug-containing layer coating is obtained; C. Protective layer coating process: Step C1, preparation of protective layer coating solution: dissolve the formula amount of povidone and magnesium stearate in 95% ethanol, and weigh the formula amount of the nicotine micro-pellet after drug-containing layer coating prepared in step B, wherein the mass percentage of the nicotine micro-pellet after drug-containing layer coating: povidone: magnesium stearate is 95.0:3.4:1.6; Step C2, protective layer coating process: the prepared povidone and magnesium stearate alcohol solution is placed in the spray gun tank, and the weighed nicotine pellets coated with the drug-containing layer are placed in the fluidized bed solid tank. The machine parameters are set according to the preset parameters, and the machine is started for fluidized bed coating process, and fluidized bed drying is carried out at the same time, for 30 minutes. The protective layer coating liquid is uniformly wrapped on the nicotine pellets coated with the drug-containing layer; Step C3: drying process: the drying process is completed at the same time of the protective layer coating, and the nicotine pellets coated with the protective layer are obtained; D. Drug-loaded layer coating process: Step D1, preparation of drug-loaded layer coating liquid: the formula amount of nicotine ditartrate dihydrate, methacrylic acid-ethyl acrylate copolymer, neotame, essence, sodium carbonate aqueous solution is dissolved with 95% ethanol to obtain solution B. The protective layer coated nicotine pellets prepared in step C are weighed according to the formula amount, and the mass percentage of the protective layer coated nicotine pellets:methacrylic acid-ethyl acrylate copolymer:sodium carbonate aqueous solution:nicotine ditartrate dihydrate:neotame:essence is 63.5:25.8:1.2:3.0:0.1:6.4; Step D2, drug-loaded layer coating process: the prepared solution B is placed in the spray gun tank, and the weighed protective layer coated nicotine pellets are placed in the fluidized bed solid tank. The machine parameters are set according to the preset parameters, and the machine is started for fluidized bed coating process, and fluidized bed drying is carried out at the same time, for 60 minutes. The nicotine-containing composition is uniformly wrapped on the nicotine pellets coated with the protective layer; Step D3, drying process: the drying process of the pellets is completed at the same time of the drug-loaded layer coating, and the nicotine pellet composition is obtained; Step D4, filling process: the nicotine pellet composition is transferred to the powder tank of the granule packaging machine, and the non-woven fabric roll is placed in the film roll tank of the granule packaging machine. The granule packaging machine is started for filling process.

2. The nicotine pellet composition of claim 1, wherein, The essence includes any one or more of bergamot essence, eucalyptus essence, lemon essence, peppermint essence, mint essence, menthol, liquorice essence, wintergreen essence, tobacco essence, coffee essence, vanilla essence, lime essence, apple essence, peach essence, mango essence, cherry essence, blueberry essence, strawberry essence, cola essence, cinnamon essence, and watermelon essence.

3. A nicotine micro-pellet pouch, characterized in that, The nicotine pellet composition of any one of claims 1-2 is contained in the non-woven fabric pouch.

4. A process for the preparation of a nicotine micro-pellet pouch, characterized in that, The nicotine pellet pouch is prepared by the method of claim 3, which is prepared by the method of forming multiple layers of drug-loaded or coated on the sucrose blank pellet core as described in claim 1.

Citation Information

Patent Citations

  • Oral Product

    CN107259634A

  • Buccal tobacco product with stable nicotine and preparation method of buccal tobacco product

    CN114521669A

  • Nicotine granule composition and preparation method thereof

    CN112220756A

  • Chewing gum products and methods of making

    CN114945359A